Why Elan Is Inviting Royalty Pharma Bid

June 17 (Bloomberg) -- Elan Corp. is seeking a buyer and will invite Royalty Pharma, whose $6.7 billion bid it rejected, to participate, suggesting the two companies may end a standoff that has lasted almost four months. Jonathan Ferro reports on Bloomberg Television's "Countdown." (Source: Bloomberg)
Tech, Financials to Be Rediscovered in 2-3 Years: Lee
16:37 - Thomas Lee, co-founder of Fundstrat Global Advisors, talks about the performance of the U.S. stock market, investment strategy and the outlook for equities, oil prices and inflation. He speaks with Alix Steel on Bloomberg Television's "Bloomberg Markets." (Source: Bloomberg)
  • Week in Review: U.S. GDP Shrinks 0.7% in 1Q
  • Humana Soars as Possible Sale Explored
  • Silk Road's 'Dread Pirate Roberts' Gets Life Sentence